Arturo Cesaro

3.3k total citations · 1 hit paper
80 papers, 1.4k citations indexed

About

Arturo Cesaro is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Arturo Cesaro has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Arturo Cesaro's work include Lipoproteins and Cardiovascular Health (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Coronary Interventions and Diagnostics (11 papers). Arturo Cesaro is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Coronary Interventions and Diagnostics (11 papers). Arturo Cesaro collaborates with scholars based in Italy, United States and United Kingdom. Arturo Cesaro's co-authors include Paolo Calabrò, Felice Gragnano, Elisabetta Moscarella, Fabio Fimiani, Giuseppe Limongelli, Ivana Pariggiano, Claudia Concilio, Vincenzo Diana, Celestino Sardu and Raffaele Marfella and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Arturo Cesaro

71 papers receiving 1.3k citations

Hit Papers

Infarct size, inflammatory burden, and admission hypergly... 2022 2026 2023 2024 2022 40 80 120

Peers

Arturo Cesaro
Arturo Cesaro
Citations per year, relative to Arturo Cesaro Arturo Cesaro (= 1×) peers Kwo‐Chang Ueng

Countries citing papers authored by Arturo Cesaro

Since Specialization
Citations

This map shows the geographic impact of Arturo Cesaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arturo Cesaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arturo Cesaro more than expected).

Fields of papers citing papers by Arturo Cesaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arturo Cesaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arturo Cesaro. The network helps show where Arturo Cesaro may publish in the future.

Co-authorship network of co-authors of Arturo Cesaro

This figure shows the co-authorship network connecting the top 25 collaborators of Arturo Cesaro. A scholar is included among the top collaborators of Arturo Cesaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arturo Cesaro. Arturo Cesaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forzano, Imma, Viviana Narciso, Mario Enrico Canonico, et al.. (2025). Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine. 14(23). 8334–8334.
2.
Vetrano, Erica, Raffaele Galiero, Vittorio Simeon, et al.. (2025). Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals. 18(8). 1200–1200.
3.
Gragnano, Felice, Arturo Cesaro, Mattía Galli, & Paolo Calabrò. (2025). AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain. European Heart Journal - Cardiovascular Pharmacotherapy. 11(3). 213–214.
4.
Abrignani, Maurizio Giuseppe, Edoardo Gronda, Marco Marini, et al.. (2024). Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem. Cardiovascular Drugs and Therapy. 39(4). 857–874. 2 indexed citations
5.
Mennitti, Cristina, Laura Sarno, Fabio Fimiani, et al.. (2024). Preliminary study on the role of human defensins, interleukins and PCSK9 in early and late preeclampsia. Reproductive Biology. 24(4). 100947–100947. 1 indexed citations
7.
Fazio, Sergio, et al.. (2024). Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor That Has Been Overlooked for Too Long. Biomedicines. 12(7). 1417–1417. 5 indexed citations
8.
Gragnano, Felice, Fabio Fimiani, Elisabetta Moscarella, et al.. (2023). De-escalation strategies in patients with acute coronary syndrome: a step towards precision medicine. Expert Review of Cardiovascular Therapy. 21(7). 545–551. 4 indexed citations
9.
Gragnano, Felice, Francesco Pelliccia, Giampaolo Niccoli, et al.. (2023). Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. Journal of Clinical Medicine. 12(8). 2810–2810. 4 indexed citations
10.
Gragnano, Felice, Antonio Micari, Francesco Costa, et al.. (2023). Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine. 13(1). 98–98. 5 indexed citations
11.
Rubino, Marta, Emanuele Monda, Martina Caiazza, et al.. (2022). Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference. SHILAP Revista de lepidopterología. 12(1). 102–108. 1 indexed citations
12.
Brancaccio, Mariarita, Cristina Mennitti, Arturo Cesaro, et al.. (2022). The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota. International Journal of Environmental Research and Public Health. 19(3). 1249–1249. 39 indexed citations
13.
Palmiero, Giuseppe, Arturo Cesaro, Erica Vetrano, et al.. (2021). Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. International Journal of Molecular Sciences. 22(11). 5863–5863. 71 indexed citations
14.
Scudiero, Olga, Barbara Lombardo, Mariarita Brancaccio, et al.. (2021). Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination. International Journal of Environmental Research and Public Health. 18(3). 904–904. 39 indexed citations
15.
Brancaccio, Mariarita, Cristina Mennitti, Sonia Laneri, et al.. (2020). Methicillin-Resistant Staphylococcus aureus: Risk for General Infection and Endocarditis Among Athletes. Antibiotics. 9(6). 332–332. 11 indexed citations
16.
Calabrò, Paolo, Felice Gragnano, Arturo Cesaro, et al.. (2019). La trombosi atriale e auricolare sinistra nei pazienti con fibrillazione atriale: dalla fisiopatologia al trattamento. Giornale italiano di cardiologia. 20(6). 374–383. 1 indexed citations
17.
Crisci, Mario, Felice Gragnano, Marco Di Maio, et al.. (2019). Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Results from the PROGRESS Trial. Current Vascular Pharmacology. 18(3). 294–301. 8 indexed citations
18.
Scudiero, Olga, Raffaela Pero, Annaluisa Ranieri, et al.. (2019). Childhood obesity: an overview of laboratory medicine, exercise and microbiome. Clinical Chemistry and Laboratory Medicine (CCLM). 58(9). 1385–1406. 13 indexed citations
19.
Gragnano, Felice, Simona Sperlongano, Enrica Golia, et al.. (2017). The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators of Inflammation. 2017. 1–13. 168 indexed citations
20.
Gragnano, Felice, Mario Crisci, Maurizio Cappelli Bigazzi, et al.. (2017). Von Willebrand Factor as a Novel Player in Valvular Heart Disease: From Bench to Valve Replacement. Angiology. 69(2). 103–112. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026